Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2011-03-09 Transaction in Own Shar…
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Daily share buy-back notice - Appendix 3E 2 pages 73.1KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It is a regulatory form specifically related to the company's repurchase of its own shares. The document length is relatively short (2637 characters) and it is not an announcement of a report publication but a direct notice of share buy-back activity. This matches the definition of 'Transaction in Own Shares' (POS) filings, which report the company's buying back or selling its own shares. Therefore, the document should be classified as POS.
2011-03-09 English
Daily share buy-back notice - Appendix 3E 2 pages 73.0KB
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's share buy-back activity, including the number of shares bought back, total consideration paid, highest and lowest prices paid, and compliance statements. It references ASX rules and is a formal notice related to the company's repurchase of its own shares. The content matches the description of a 'Transaction in Own Shares' filing, which reports on share repurchase activities. The document length is relatively short (2642 characters), but it contains substantive data about the buy-back, not just an announcement of a report. Therefore, it should be classified as a Transaction in Own Shares (POS) filing rather than a report publication announcement or regulatory filing.
2011-03-08 English
Daily share buy-back notice - Appendix 3E 2 pages 73.1KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and references ASX rules related to share buy-backs. It provides detailed information about the number of shares bought back, prices paid, compliance statements, and participation by directors. The document is a formal notice about the company's share repurchase activity, specifically an on-market buy-back. It does not contain financial statements or broader financial performance data, nor is it an announcement of a report publication. This fits the definition of a 'Transaction in Own Shares' filing, which reports the company's buying back or selling its own shares.
2011-03-07 English
Daily share buy-back notice - Appendix 3E 2 pages 73.1KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It references ASX rules and is a formal notice related to the company's repurchase of its own shares. The content is specific to share repurchase transactions rather than financial results, management changes, or regulatory announcements. The document length is 2643 characters, which is typical for a detailed transaction notice. Therefore, the document fits the category of 'Transaction in Own Shares' (POS).
2011-03-06 English
Daily share buy-back notice - Appendix 3E 2 pages 73.1KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's share buy-back activity, including number of shares bought back, prices paid, dates, and compliance statements. It references ASX rules and is a formal notice related to the company's repurchase of its own shares. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's buying back or selling its own shares. The document length is short and focused solely on buy-back details, not a broader financial report or announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2011-03-03 English
Daily share buy-back notice - Appendix 3E 2 pages 73.0KB
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It references ASX rules and is a formal notice related to share repurchase activity. The document length is 2651 characters, which is relatively short but contains substantive data about share buy-back transactions. This matches the description of 'Transaction in Own Shares' filings, which report company buy-back or sale of its own shares. Therefore, the document is best classified as a Transaction in Own Shares (POS) filing.
2011-03-02 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.